The Antiviral activities of the cationic host defence peptide LL-37 against Rhinovirus

Prof Peter Barlow P.Barlow@napier.ac.uk
Professor

Cathelicidins as novel therapeutic antiviral agents in Rhinovirus infection May 1, 2015 - Jun 30, 2017
We have identified the human cathelicidn LL-37 as having potent direct antiviral activity against human rhinovirus (HRV), together with the capacity to alter death pathways in HRV-infected cells, as a potential host defence mechanism. We propose to c... Read More about Cathelicidins as novel therapeutic antiviral agents in Rhinovirus infection.

Electrolysed Water for Post-Harvest Washing (JadooJal) Mar 1, 2017 - Aug 31, 2019
assist the development of a novel electrolysed water based application to reduce spoilage and microbial contamination of a variety of fresh produce types of importance to Indian commerce.

TRANSFORM - Education reform project – Improving Research capability in the Sri Lankan Higher Education sector. Apr 1, 2018 - Oct 21, 2019
TRANSFORM - Education reform project – Improving Research capability in the Sri Lankan Higher Education sector.

Cathelicidins as Novel Therapeutic Antivirals for Dengue Infection Apr 1, 2019 - Mar 31, 2022
A significant challenge faced by modern society is the lack of therapeutics for a large number of infections, particularly those that are endemic or widely spread in developing countries. Dengue is one such infection which is endemic inIndonesia - it... Read More about Cathelicidins as Novel Therapeutic Antivirals for Dengue Infection.

Host Defence Peptides as novel modulators of autophagy in Inflammatory Bowel Disease Oct 1, 2019 - Dec 31, 2022
Increasing numbers of patients are diagnosed with inflammatory bowel disease (IBD) each year, both in the United Kingdom and worldwide. Most drugs in current use for the treatment of IBD target the immune system to reduce inflammation and induce remi... Read More about Host Defence Peptides as novel modulators of autophagy in Inflammatory Bowel Disease.